President Donald Trump Announces ‘Most Favored Nation’ Pricing Agreements with Nine Major Pharmaceutical Companies to Reduce United States Drug Costs
Washington, D.C. – On Friday, December 19, 2025, President Donald Trump announced voluntary agreements with nine leading pharmaceutical companies to implement “Most Favored Nation” (MFN) pricing on select drugs, aiming to align U.S. prices with …
